Research Output per year
Fingerprint Dive into the research topics where Brian Jonas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output
A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic Malignancies
Hoeg, R. T., Davis, J., Jonas, B. A., Tuscano, J., Rosenberg, A. & Abedi, M., Jan 1 2020, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article
A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia
Tomlinson, B. K., Tuscano, J., Abedi, M., Welborn, J. L., Arora, M., O'Donnell, R. T., Wun, T. & Jonas, B., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.Research output: Contribution to journal › Letter
4
Scopus
citations
Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma
Rosenberg, A., Brunson, A., Jonas, B., Keegan, T. H. & Wun, T., Jan 1 2019, In : Journal of the National Cancer Institute. 111, 1, p. 78-85 8 p.Research output: Contribution to journal › Article
3
Scopus
citations
Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia
Cortes, J. E., Jonas, B., Graef, T., Luan, Y. & Stein, A. S., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article
Open Access
1
Scopus
citations
Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia
Lin, T-Y., Zhu, Y., Li, Y., Zhang, H., Ma, A. H., Long, Q., Keck, J., Lam, K., Pan, C-X. & Jonas, B., Aug 1 2019, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 20, 102004.Research output: Contribution to journal › Article
4
Scopus
citations